161 related articles for article (PubMed ID: 37588747)
1. Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma.
Zhang Y; Wang G; Wang M
Transl Cancer Res; 2023 Jul; 12(7):1684-1702. PubMed ID: 37588747
[TBL] [Abstract][Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
3. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
Shang BB; Chen J; Wang ZG; Liu H
PeerJ; 2021; 9():e12315. PubMed ID: 34754620
[TBL] [Abstract][Full Text] [Related]
4. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
5. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
[No Abstract] [Full Text] [Related]
6. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
7. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract][Full Text] [Related]
8. Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.
Xie H; Yang K; Qin C; Zhou X; Liu J; Nong J; Luo J; Wei Y; Hua H; Han C; Liao X; Yang C; Su H; Zhu G; Ye X; Peng T
J Cancer; 2024; 15(1):149-165. PubMed ID: 38164283
[TBL] [Abstract][Full Text] [Related]
9. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Liu J; Liu T; Zhang C; He J; Zhou D; Wang Z; Wang R
Front Genet; 2022; 13():992343. PubMed ID: 36276981
[No Abstract] [Full Text] [Related]
10. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
12. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
13. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
14. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
16.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
17. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Liu R; Wang G; Zhang C; Bai D
World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
[TBL] [Abstract][Full Text] [Related]
18. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
[TBL] [Abstract][Full Text] [Related]
19. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]